Patent Applications published on Dec 5, 2019 - page 4

#901
US20190365616A1
Human necessities

Activation And Stabilization Of Basic Aluminum Chloride Solution By Zinc

#902
US20190365617A1
Human necessities

RINSE-OFF CLEANSING COMPOSITIONS COMPRISING MATERIALS THAT MODIFY SEBUM

#903 ✅ Patent 10,993,894 granted on 2021-05-04
US20190365618A1
Human necessities

Methods of preparing non-alcohol bioactive essential oil mouth rinses

#904
US20190365619A1
Human necessities

ANTI-DANDRUFF CLEANSING COMPOSITION

#905 ✅ Patent 10,933,004 granted on 2021-03-02
US20190365620A1
Human necessities

Cosmetic composition

#906 ✅ Patent 10,639,258 granted on 2020-05-05
US20190365621A1
Human necessities

Oral care compositions

#907 ✅ Patent 11,096,878 granted on 2021-08-24
US20190365622A1
Human necessities

Concentrated rinse-off cleansing composition

#908
US20190365623A1
Human necessities

NON-SULFATE CONCENTRATED RINSE-OFF CLEANSING COMPOSITION

#909
US20190365624A1
Human necessities

Aqueous Surfactant Compositions

#910 ✅ Patent 10,596,091 granted on 2020-03-24
US20190365625A1
Human necessities

Hair color-altering compositions

#911
US20190365626A1
Human necessities

HIGHLY EFFECTIVE PHOTOPROTECTIVE AGENTS

#912 ✅ Patent 11,191,712 granted on 2021-12-07
US20190365627A1
Human necessities

Skin treatment compositions, masks, and related methods

#913
US20190365628A1
Human necessities

COMPOSITION IN THE FORM OF NANO- OR MICRO- EMULSION

#914 ✅ Patent 12,337,056 granted on 2025-06-24
US20190365629A1
Human necessities

TOPICAL COMPOSITIONS AND METHODS

#915
US20190365630A1
Human necessities

ANTIBACTERIAL PARTICLES AND METHODS

#916
US20190365631A1
Human necessities

NAIL ENAMEL COMPOSITION

#917 ✅ Patent 10,765,619 granted on 2020-09-08
US20190365632A1
Human necessities

Silicone resin, making method, and cosmetics

#918
US20190365633A1
Human necessities

METHOD OF TREATING HAIR WITH A CONCENTRATED CONDITIONER

#919
US20190365634A1
Human necessities

Human Axilla Cleansing Compound

#920
US20190365635A1
Human necessities

Facial Hydrating Oil

#921 ✅ Patent 10,780,044 granted on 2020-09-22
US20190365636A1
Human necessities

Natural and organic deodorant and method of making the deodorant

#922
US20190365637A1
Human necessities

CYTOMIMETIC FORMULATIONS AND METHODS OF MANUFACTURING THE SAME

#923 ✅ Patent 11,179,319 granted on 2021-11-23
US20190365638A1
Human necessities

Method for producing cosmetic composition using skin serum

#924 ✅ Patent 11,260,022 granted on 2022-03-01
US20190365639A1
Human necessities

Method for producing oral composition, and oral composition

#925 ✅ Patent 11,446,234 granted on 2022-09-20
US20190365640A1
Human necessities

CH53 strain having high productivity of 1,3-propanediol from glycerol and uses thereof

#926
US20190365641A1
Human necessities

RAPIDLY DISINTEGRATING FORMULATIONS AND METHODS OF USE

#927 ✅ Patent 12,042,558 granted on 2024-07-23
US20190365642A1
Human necessities

Method and formulation for improving roflumilast skin penetration lag time

#928 ✅ Patent 10,912,735 granted on 2021-02-09
US20190365643A1
Human necessities

Injectable composition with aromatase inhibitor

#929
US20190365644A1
Human necessities

DRUG DELIVERY SYSTEM

#930
US20190365645A1
Human necessities

DRUG DELIVERY ARTICLES FOR GRAM-LEVEL DOSING

#931 ✅ Patent 11,285,102 granted on 2022-03-29
US20190365646A1
Human necessities

Expandable gastroretentive dosage form

#932 ✅ Patent 11,617,718 granted on 2023-04-04
US20190365647A1
Human necessities

Process for producing a nano-CBD microemulsion system

#933 ✅ Patent 11,285,106 granted on 2022-03-29
US20190365648A1
Human necessities

Synthetic nanostructures including nucleic acids and/or other entities

#934
US20190365649A1
Human necessities

COMPOSITIONS COMPRISING LIPOSOME-ENCAPSULATED THIAZOLIDINEDIONES AND LIPOSOME-ENCAPSULATED VASODILATORS, AND THEIR USE TO AMELIORATE ATHEROMA

#935 ✅ Patent 11,337,924 granted on 2022-05-24
US20190365650A1
Human necessities

Targeted polymerized nanoparticles for cancer treatment

#936 ✅ Patent 11,576,861 granted on 2023-02-14
US20190365651A1
Human necessities

Sustained release particle formulations

#937 ✅ Patent 11,071,714 granted on 2021-07-27
US20190365652A1
Human necessities

Poly(ketals) and related compositions and methods

#938
US20190365653A1
Human necessities

NOVEL RECOMBINANT EXOSOME CONTAINING HYALURONIDASE AND USE THEREOF

#939
US20190365654A1
Human necessities

APPARATUS AND PROCESS FOR ENCAPSULATING CAPSULES OR OTHER SOLID DOSAGE FORMS WITHIN CAPSULES

#940 ✅ Patent 11,026,893 granted on 2021-06-08
US20190365655A1
Human necessities

Taste masking drug formulations

#941
US20190365656A1
Human necessities

PARTICLES ENCAPSULATING FUSION PROTEINS CONTAINING LINKED EPITOPES

#942
US20190365657A1
Human necessities

TUMOR-TARGETING BEAD VECTORS AND METHODS OF USING THE SAME

#943 ✅ Patent 12,268,785 granted on 2025-04-08
US20190365658A1
Human necessities

Coated edible plant-derived microvesicle compositions and methods for using the same

#944 ✅ Patent 11,446,254 granted on 2022-09-20
US20190365659A1
Human necessities

Drug carrier having self-assembled 3-D nucleic acid nanostructure

#945 ✅ Patent 11,406,604 granted on 2022-08-09
US20190365660A1
Human necessities

Nanocapsules and method for manufacturing thereof

#946 ✅ Patent 11,419,769 granted on 2022-08-23
US20190365661A1
Human necessities

Sublingual films

#947 ✅ Patent 11,752,109 granted on 2023-09-12
US20190365662A1
Human necessities

Controlling water release from a dimensionally stable aqueous composition

#948
US20190365663A1
Human necessities

METHOD FOR MAKING A TRANSDERMAL FENTANYL PATCH WITH EVEN DRUG CRYSTAL DISTRIBUTION

#949
US20190365664A1
Human necessities

CARYOPHYLLENE FORMULATIONS, APPARATUSES, AND METHODS

#950
US20190365665A1
Human necessities

ISO-OSMOTIC AND NEAR ISO-OSMOTIC OXYGEN THERAPEUTIC FORMULATIONS AND METHODS THEREOF

#951
US20190365666A1
Human necessities

METHODS FOR PREVENTION AND TREATMENT OF CARDIOMETABOLIC SYNDROME AND COMPOSITIONS USED THEREIN

#952 ✅ Patent 11,426,362 granted on 2022-08-30
US20190365667A1
Human necessities

Oral cannabinoid formulations

#953 ✅ Patent 10,493,044 granted on 2019-12-03
US20190365668A1
Human necessities

Method for treating developmental retinal vascular disorder

#954 ✅ Patent 11,116,731 granted on 2021-09-14
US20190365669A1
Human necessities

Hydrogen sulfide and/or nitrite in the treatment and prevention of atrial fibrillation

#955 ✅ Patent 11,007,155 granted on 2021-05-18
US20190365670A1
Human necessities

Method for producing a sea urchin extract enriched with 1,4-polyhydroxylated naphthoquinones with antimicrobial and antioxidant activity

#956
US20190365671A1
Human necessities

COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATING OXIDATIVE DNA DAMAGE DISORDERS

#957
US20190365672A1
Human necessities

Transmucosal Ketamine Delivery Composition

#958
US20190365673A1
Human necessities

Immunomodulatory Compounds

#959
US20190365674A1
Human necessities

USE OF RASAGILINE FOR THE TREATMENT OF RESTLESS LEGS SYNDROME

#960
US20190365675A1
Human necessities

COMPOSITIONS FOR THE PREVENTION AND/OR TREATMENT OF ALCOHOL USE DISORDERS

#961 ✅ Patent 11,801,231 granted on 2023-10-31
US20190365676A1
Human necessities

Oral compositions and methods of use

#962 ✅ Patent 11,141,389 granted on 2021-10-12
US20190365677A1
Human necessities

Agents that inhibit NGLY1 and methods of use thereof

#963
US20190365678A1
Human necessities

Method for Treating Pain

#964 ✅ Patent 11,065,216 granted on 2021-07-20
US20190365679A1
Human necessities

Compositions and methods for regulating body weight and metabolic syndromes

#965
US20190365680A1
Human necessities

USE OF EP4 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF NASH-ASSOCIATED LIVER CANCER

#966
US20190365681A1
Human necessities

TREATMENT OF CANCER WITH COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES

#967
US20190365682A1
Human necessities

TOPICAL ANTI-INFLAMMATORY COMPOSITIONS

#968 ✅ Patent 10,668,034 granted on 2020-06-02
US20190365683A1
Human necessities

Pharmaceutical compositions and the treatment of overactive bladder

#969
US20190365684A1
Human necessities

INHIBITORS OF PLASMINOGEN FOR TREATING, REDUCING OR PREVENTING RADIATION-INDUCED INJURIES

#970
US20190365685A1
Human necessities

EYE DROPS FOR TREATING DRY EYE

#971
US20190365686A1
Human necessities

EYE DROPS FOR TREATING DRY EYE

#972 ✅ Patent 10,588,882 granted on 2020-03-17
US20190365687A1
Human necessities

Pharmaceutical suspensions containing drug particles, devices for their administration, and methods of their use

#973 ✅ Patent 10,925,848 granted on 2021-02-23
US20190365688A1
Human necessities

Amide derivative

#974
US20190365689A1
Human necessities

USE OF APE/REF-1 REDOX SPECIFIC INHIBITORS FOR TREATING METASTATIC PROSTATE CANCER

#975
US20190365690A1
Human necessities

Use of Derivatives of Polyunsaturated Fatty Acids as Medicaments

#976 ✅ Patent 11,013,709 granted on 2021-05-25
US20190365691A1
Human necessities

Highly purified eicosapentaenoic acid, as free fatty acid, reduces fecal calprotectin levels and prevents clinical relapse in ulcerative colitis patients

#977
US20190365692A1
Human necessities

OPHTHALMIC COMPOSITIONS AND METHODS FOR TREATING EYES

#978
US20190365693A1
Human necessities

INDUCTION OF ARTERIOGENESIS

#979
US20190365694A1
Human necessities

COMPOSITION OF MATTER AND USE THEREOF FOR PREVENTING AND TREATING MOTION SICKNESS

#980
US20190365695A1
Human necessities

ANAPLEROTIC THERAPY OF HUNTINGTON DISEASE AND OTHER POLYGLUTAMINE DISEASES

#981 ✅ Patent 10,583,107 granted on 2020-03-10
US20190365696A1
Human necessities

Method for treating benign prostatic hyperplasia (BPH), prostatitis, and prostate cancer

#982
US20190365697A1
Human necessities

Method for Treating Liver Dysfunction

#983
US20190365698A1
Human necessities

Use of Antineoplastic Agents to Stimulate the Immune System for Treatment of Cancer

#984
US20190365699A1
Human necessities

Treatment of Kidney Tumors by Intratumoral Injection of Taxane Particles

#985
US20190365700A1
Human necessities

Methods for Isolating Tumor-Specific Immune Cells from a Subject for Adoptive Cell Therapy and Cancer Vaccines

#986 ✅ Patent 10,912,755 granted on 2021-02-09
US20190365701A1
Human necessities

Arginase inhibitors and their therapeutic applications

#987 ✅ Patent 10,512,629 granted on 2019-12-24
US20190365702A1
Human necessities

Compositions comprising a cannabinoid and spilanthol

#988 ✅ Patent 11,033,528 granted on 2021-06-15
US20190365703A1
Human necessities

Method and composition for preventing and treating viral infections

#989
US20190365704A1
Human necessities

SOLUBLE EPOXIDE HYDROLASE AS A TARGET FOR OCULAR DISEASES

#990
US20190365705A1
Human necessities

TOPICAL TOCOTRIENOL COMPOSITIONS AND METHODS OF INCREASING SKIN STEM CELLS

#991 ✅ Patent 11,173,140 granted on 2021-11-16
US20190365706A1
Human necessities

Dosing regimens of PKC activators

#992
US20190365707A1
Human necessities

METHODS OF AMELIORATING POST-DIALYSIS WASHOUT AND NUTRITIONAL SUPPLEMENTS FOR USE IN SUCH METHODS

#993 ✅ Patent 10,857,129 granted on 2020-12-08
US20190365708A1
Human necessities

Vreceptor antagonist for use in the treatment of patients having an elevated AVP level and/or an elevated copeptin level

#994
US20190365709A1
Human necessities

Use Of [(1R)-1-(2-Chlorophenyl)-2-(Tetrazol-2-YL)Ethyl] Carbamate In Combination Therapy

#995
US20190365710A1
Human necessities

METHODS OF TREATING CANCER

#996 ✅ Patent 11,712,434 granted on 2023-08-01
US20190365711A1
Human necessities

Compound having anti-cancer effect, and preparation method therefor and use thereof

#997 ✅ Patent 11,020,376 granted on 2021-06-01
US20190365712A1
Human necessities

Crystalline form of lorlatinib free base

#998 ✅ Patent 10,751,325 granted on 2020-08-25
US20190365713A1
Human necessities

Stabilized oxymetazoline formulations and their uses

#999 ✅ Patent 11,090,289 granted on 2021-08-17
US20190365714A1
Human necessities

Compositions and methods for blocking sodium channels

#1000 ✅ Patent 11,839,604 granted on 2023-12-12
US20190365715A1
Human necessities

Use of sublingual dexmedetomidine for the treatment of agitation

#1001 ✅ Patent 10,583,125 granted on 2020-03-10
US20190365716A1
Human necessities

Method for treating neurodegenerative diseases

#1002
US20190365717A1
Human necessities

TREATING PATHOLOGICAL CONDITIONS BY DIRECT AND INDIRECT TARGETING OF SIRPA-CD47 INTERACTION

#1003 ✅ Patent 11,173,145 granted on 2021-11-16
US20190365718A1
Human necessities

Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase

#1004
US20190365719A1
Human necessities

COMBINATION TREATMENTS OF HSP90 INHIBITORS FOR ENHANCING TUMOR IMMUNOGENICITY AND METHODS OF USE THEREOF

#1005
US20190365720A1
Human necessities

Novel formulations of amidine substituted beta-lactam compounds on the basis of modified cyclodextrins and acidifying agents, their preparation and use as antimicrobial pharmaceutical compositions

#1006 ✅ Patent 11,083,711 granted on 2021-08-10
US20190365721A1
Human necessities

Amine prodrugs of pharmaceutical compounds

#1007 ✅ Patent 10,993,935 granted on 2021-05-04
US20190365722A1
Human necessities

Compositions and methods for treatment of lung infections

#1008 ✅ Patent 11,040,027 granted on 2021-06-22
US20190365723A1
Human necessities

Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death

#1009 ✅ Patent 10,532,043 granted on 2020-01-14
US20190365724A1
Human necessities

Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof

#1010 ✅ Patent 10,507,200 granted on 2019-12-17
US20190365725A1
Human necessities

Therapeutics compositions containing harmine and isovanillin components, and methods of use thereof

#1011 ✅ Patent 10,947,199 granted on 2021-03-16
US20190365726A1
Human necessities

Spiro and cyclic bis-benzylidene proteasome inhibitor for the treatment of cancer, diabetes and neurological disorders

#1012 ✅ Patent 10,786,488 granted on 2020-09-29
US20190365727A1
Human necessities

Substituted quinolizine derivatives useful as HIV integrase inhibitors

#1013
US20190365728A1
Human necessities

PHARMACEUTICAL COMPOSITION COMPRISING BETAHISTINE

#1014 ✅ Patent 11,266,637 granted on 2022-03-08
US20190365729A1
Human necessities

Formulations of tegavivint and related compounds

#1015
US20190365730A1
Human necessities

ANAESTHETIC COMPOSITION COMPRISING ROPIVACAINE, PRILOCAINE AND LIDOCAINE

#1016 ✅ Patent 11,191,754 granted on 2021-12-07
US20190365731A1
Human necessities

Inhibitors of nucleotidyl transferases and uses in herpes and hepatitis viral infections therefor

#1017 ✅ Patent 11,197,848 granted on 2021-12-14
US20190365732A1
Human necessities

Topical amlodipine salts for the treatment of anorectal diseases

#1018 ✅ Patent 11,690,837 granted on 2023-07-04
US20190365733A1
Human necessities

Methods of improving cell-based therapy

#1019 ✅ Patent 11,179,379 granted on 2021-11-23
US20190365734A1
Human necessities

Compositions and methods for hemoglobin production

#1020
US20190365735A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING VARICOSE VEINS

#1021
US20190365736A1
Human necessities

ANTICHOLINERGIC NEUROPROTECTIVE COMPOSITION AND METHODS

#1022 ✅ Patent 10,894,043 granted on 2021-01-19
US20190365737A1
Human necessities

Pharmaceutical composition

#1023
US20190365738A1
Human necessities

AMORPHOUS SOLID DISPERSION OF VALBENAZINE TOSYLATE AND PROCESS FOR PREPARATION THEREOF

#1024
US20190365739A1
Human necessities

TRANSMUCOSAL DELIVERY DEVICES WITH ENHANCED UPTAKE

#1025 ✅ Patent 11,123,345 granted on 2021-09-21
US20190365740A1
Human necessities

Prevention and/or treatment of contrast-induced acute kidney injury

#1026
US20190365741A1
Human necessities

COMBINATIONS OF THE CDK4/6 INHIBITOR LEE011 AND THE MEK1/2 INHIBITOR TRAMETINIB, OPTIONALLY FURTHER COMPRISING THE PI3K INHIBITOR BYL719 TO TREAT CANCER

#1027
US20190365742A1
Human necessities

AZOLE TREATMENT REGIMEN WITH REDUCED HEPATOTOXICITY

#1028
US20190365743A1
Human necessities

HEDGEHOG PATHWAY INHIBITION FOR TREATMENT OF HIGH-RISK BASAL CELL CARCINOMA OR HIGH-RISK BASAL CELL CARCINOMA NEVUS SYNDROME

#1029
US20190365744A1
Human necessities

IMPROVED MULTI TYROSINE KINASE INHIBITOR THERAPY

#1030
US20190365745A1
Human necessities

USE OF CHRONIC TREATMENT WITH ATR INHIBITORS TO SENSITIZE CANCER CELLS TO PARP INHIBITORS

#1031 ✅ Patent 11,406,633 granted on 2022-08-09
US20190365746A1
Human necessities

Dosing schedule of a Wnt inhibitor and an anti-PD-1 antibody molecule in combination

#1032 ✅ Patent 10,561,652 granted on 2020-02-18
US20190365747A1
Human necessities

Benzenesulfonamide derivatives of quinoxaline, pharmaceutical compositions thereof, and their use in methods for treating cancer

#1033 ✅ Patent 10,603,318 granted on 2020-03-31
US20190365748A1
Human necessities

Inhibitors of hepatitis C virus

#1034 ✅ Patent 10,953,006 granted on 2021-03-23
US20190365749A1
Human necessities

Composition for reducing nervous system injury and method of making and use thereof

#1035 ✅ Patent 10,898,484 granted on 2021-01-26
US20190365750A1
Human necessities

Method of reducing pulmonary exacerbations in respiratory disease patients

#1036
US20190365751A1
Human necessities

IMMEDIATE RELEASE PHARMACEUTICAL FORMULATION OF 4-[3-(4-CYCLOPROPANECARBONYL-PIPERAZINE-1-CARBONYL)-4-FLUORO-BENZYL]-2H-PHTHALAZIN-1-ONE

#1037 ✅ Patent 10,792,283 granted on 2020-10-06
US20190365752A1
Human necessities

Quinoline analogs as phosphatidylinositol 3-kinase inhibitors

#1038 ✅ Patent 11,033,545 granted on 2021-06-15
US20190365753A1
Human necessities

Negative allosteric modulators of MGLUR5 for use in the treatment of mature brain damages

#1039
US20190365754A1
Human necessities

METHOD OF ELIMINATING STEM CELLS

#1040 ✅ Patent 11,052,086 granted on 2021-07-06
US20190365755A1
Human necessities

2-anilinopyrimidine derivatives as therapeutic agents for treatment of brain cancers

#1041 ✅ Patent 10,857,153 granted on 2020-12-08
US20190365756A1
Human necessities

Pyrimidine compounds containing acidic groups

#1042 ✅ Patent 10,765,677 granted on 2020-09-08
US20190365757A1
Human necessities

Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof

#1043 ✅ Patent 11,129,831 granted on 2021-09-28
US20190365758A1
Human necessities

Identification of agents displaying functional activation of dopamine D2 and D4 receptors

#1044 ✅ Patent 10,960,003 granted on 2021-03-30
US20190365759A1
Human necessities

Pyrazole pyrimidine derivative and uses thereof

#1045
US20190365760A1
Human necessities

A THERAPEUTIC OR PROPHYLACTIC AGENT FOR ISCHEMIC DISEASE, GLAUCOMA, OPTIC NERVE DISEASE, RETINAL DEGENERATIVE DISEASE, ANGIOGENIC RETINAL DISEASE, CANCER, NEURODEGENERATIVE OR AUTOIMMUNE DISEASE, AND A HYPOXIA INDUCING FACTOR INHIBITOR

#1046 ✅ Patent 10,772,889 granted on 2020-09-15
US20190365761A1
Human necessities

Liquid nutritional composition containing 5-methyltetrahydrofolic acid

#1047
US20190365762A1
Human necessities

MEDICINAL COMPOSITION INHIBITING NEOVASCULARIZATION PROLIFERATION FACTOR

#1048 ✅ Patent 10,758,542 granted on 2020-09-01
US20190365763A1
Human necessities

Substituted pyrazolo[l,5-a]pyrimidine compounds as Trk kinase inhibitors

#1049 ✅ Patent 12,226,418 granted on 2025-02-18
US20190365764A1
Human necessities

Dosing regimen for the treatment of PI3K related disorders

#1050 ✅ Patent 11,701,358 granted on 2023-07-18
US20190365765A1
Human necessities

Methods of inhibiting serum glucocorticoid induced kinase 1 (SGKI) as a treatment for salt and water balance diseases

#1051 ✅ Patent 10,736,899 granted on 2020-08-11
US20190365766A1
Human necessities

Animal and human anti-malarial agents

#1052 ✅ Patent 11,129,834 granted on 2021-09-28
US20190365767A1
Human necessities

Combinations and methods comprising a capsid assembly inhibitor

#1053 ✅ Patent 11,052,092 granted on 2021-07-06
US20190365768A1
Human necessities

N-{[2-(piperidin-1-yl)phenyl](phenyl)methyl}-2-(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-7-yl)acetamide derivatives and related compounds as ROR-gamma modulators for treating autoimmune diseases

#1054 ✅ Patent 10,869,871 granted on 2020-12-22
US20190365769A1
Human necessities

Compositions and methods of modulating short-chain dehydrogenase activity

#1055 ✅ Patent 10,966,986 granted on 2021-04-06
US20190365770A1
Human necessities

Compounds, compositions and methods for cancer patient stratification and cancer treatment

#1056
US20190365771A1
Human necessities

APILIMOD COMPOSITIONS AND METHODS FOR USING SAME IN THE TREATMENT OF ALZHEIMER'S DISEASE

#1057 ✅ Patent 10,596,180 granted on 2020-03-24
US20190365772A1
Human necessities

Salts and solid forms of (S)-3-(4-((4-(morpholinomethyl)benzyl) oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione and compositions comprising and methods of using the same

#1058 ✅ Patent 10,953,016 granted on 2021-03-23
US20190365773A1
Human necessities

Solid dosage form containing quinazoline derivative

#1059
US20190365774A1
Human necessities

COMBINATION THERAPY OF BACE-1 INHIBITOR AND ANTI-N3PGLU ABETA ANTIBODY

#1060 ✅ Patent 10,857,155 granted on 2020-12-08
US20190365775A1
Human necessities

Compounds targeting proteins, compositions, methods, and uses thereof

#1061
US20190365776A1
Human necessities

THERAPEUTIC AGENT FOR OCULAR FUNDUS DISEASE

#1062 ✅ Patent 11,026,952 granted on 2021-06-08
US20190365777A1
Human necessities

Small molecules for mouse satellite cell proliferation

#1063
US20190365778A1
Human necessities

TREPROSTINIL ADMINISTRATION BY INHALATION

#1064 ✅ Patent 12,018,402 granted on 2024-06-25
US20190365779A1
Human necessities

Methods for detecting intracranial neoplasms

#1065 ✅ Patent 11,433,083 granted on 2022-09-06
US20190365780A1
Human necessities

High-strength testosterone undecanoate compositions

#1066 ✅ Patent 11,957,695 granted on 2024-04-16
US20190365781A1
Human necessities

Methods and compositions targeting glucocorticoid signaling for modulating immune responses

#1067
US20190365782A1
Human necessities

HALOBETASOL FOAM COMPOSITION AND METHOD OF MANUFACTURE THEREOF

#1068
US20190365783A1
Human necessities

HALOBETASOL FOAM COMPOSITION AND METHOD OF MANUFACTURE THEREOF

#1069
US20190365784A1
Human necessities

USE OF BRASSINOSTEROID ANALOGS FOR THE TREATMENT OF DERMAL DISORDERS BY SELECTIVELY MODULATING LIVER X RECEPTORS (LXR) AND DERMAL DISEASE TREATMENT BY BRASSINOSTEROID ANALOGS ACTING AS SELECTIVE LIVER X RECEPTOR (LXR) MODULATORS

#1070
US20190365785A1
Human necessities

INHIBITION OF UNFOLDED PROTEIN RESPONSE FOR SUPPRESSING OR PREVENTING ALLERGIC REACTION TO FOOD

#1071
US20190365786A1
Human necessities

PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF 4-PREGENEN-11BETA-17-21-TRIOL-3,20-DIONE DERIVATIVES

#1072
US20190365787A1
Human necessities

ANTI-FATIGUE COMPOSITION

#1073
US20190365788A1
Human necessities

CYCLIC PHOSPHATE SUBSTITUTED NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF LIVER DISEASES

#1074 ✅ Patent 11,484,542 granted on 2022-11-01
US20190365789A1
Human necessities

Specialized tongue spray containing gymnemic acid and exogenous ketones

#1075
US20190365790A1
Human necessities

Compounds, Compositions and Methods for Prevention or Treatment of Liver and Lipid-related Conditions

#1076 ✅ Patent 11,413,300 granted on 2022-08-16
US20190365791A1
Human necessities

Synergistic combination of thermolysin and an antibacterial agent to reduce or eliminate bacterial biofilms from surfaces

#1077 ✅ Patent 11,446,321 granted on 2022-09-20
US20190365792A1
Human necessities

Combination therapy for treating cancer

#1078
US20190365793A1
Human necessities

CENTRAL NERVOUS SYSTEM TARGETING POLYNUCLEOTIDES

#1079 ✅ Patent 10,772,904 granted on 2020-09-15
US20190365794A1
Human necessities

Methods and compositions for treating cancers using antisense

#1080
US20190365795A1
Human necessities

OLIGONUCLEOTIDES FOR MODULATING ATXN2 EXPRESSION

#1081 ✅ Patent 10,716,804 granted on 2020-07-21
US20190365796A1
Human necessities

Crosslinked chondroitin sulfate, composition containing same, and treatment agent for eye disease

#1082
US20190365797A1
Human necessities

Systems and Methods for Delivery of Nitric Oxide

#1083 ✅ Patent 10,639,326 granted on 2020-05-05
US20190365798A1
Human necessities

Method of administration and treatment

#1084
US20190365799A1
Human necessities

THERAPIES FOR THE TREATMENT OF LIDOCAINE-INEFFECTIVE AND HYPOKALEMIC CONDITIONS

#1085 ✅ Patent 11,738,044 granted on 2023-08-29
US20190365800A1
Human necessities

Extended use zirconium silicate compositions and methods of use thereof

#1086
US20190365801A1
Human necessities

IRON OXIDE/NANOKAOLIN COMPOSITE HEMOSTATIC AGENT AND PREPARATION METHOD THEREOF

#1087
US20190365802A1
Human necessities

Oral Delivery Product

#1088
US20190365803A1
Human necessities

NANOSTRAWS METHODS AND APPARATUSES

#1089 ✅ Patent 11,058,721 granted on 2021-07-13
US20190365804A1
Human necessities

Composition comprising a substantially pure population of multipotent stromal cells encapsulated in platelet-poor plasma (PPP)

#1090 ✅ Patent 12,121,539 granted on 2024-10-22
US20190365805A1
Human necessities

Chimeric antigen receptors and uses thereof

#1091
US20190365806A1
Human necessities

IMMUNOLOGICALLY DISCERNIBLE CELL SURFACE VARIANTS FOR USE IN CELL THERAPY

#1092 ✅ Patent 10,576,103 granted on 2020-03-03
US20190365807A1
Human necessities

Immune cells defective for SUV39H1

#1093 ✅ Patent 10,736,919 granted on 2020-08-11
US20190365808A1
Human necessities

Materials and methods for engineering cells and uses thereof in immuno-oncology

#1094 ✅ Patent 10,857,184 granted on 2020-12-08
US20190365809A1
Human necessities

Materials and methods for engineering cells and uses thereof in immuno-oncology

#1095 ✅ Patent 10,675,305 granted on 2020-06-09
US20190365810A1
Human necessities

Coordinating gene expression using RNA destabilizing elements

#1096 ✅ Patent 11,564,944 granted on 2023-01-31
US20190365811A1
Human necessities

Fractal combination therapy

#1097 ✅ Patent 11,752,172 granted on 2023-09-12
US20190365812A1
Human necessities

Natural killer (NK) cells expressing an antigen-specific functional T cell receptor (TCR) complex, methods for production thereof, and methods for therapeutic use thereof

#1098 ✅ Patent 11,547,725 granted on 2023-01-10
US20190365813A1
Human necessities

Anti-cancer T cells and their preparation using coenzyme A

#1099
US20190365814A1
Human necessities

VCN ENHANCER COMPOSITIONS AND METHODS OF USING THE SAME

#1100 ✅ Patent 11,707,486 granted on 2023-07-25
US20190365815A1
Human necessities

Natural killer cell expressing anti-cotinine chimeric antigen receptor

#1101 ✅ Patent 10,736,921 granted on 2020-08-11
US20190365816A1
Human necessities

Genetically modified NK-92 cells and monoclonal antibodies for the treatment of cancer

#1102 ✅ Patent 10,828,333 granted on 2020-11-10
US20190365817A1
Human necessities

Point-of-care and/or portable platform for gene therapy

#1103
US20190365818A1
Human necessities

GENETICALLY-TAGGED STEM CELL LINES AND METHODS OF USE

#1104 ✅ Patent 11,369,640 granted on 2022-06-28
US20190365819A1
Human necessities

Compositions for biological systems and methods for preparing and using the same

#1105 ✅ Patent 12,350,295 granted on 2025-07-08
US20190365820A1
Human necessities

COMPLEX FOR PROMOTING CARTILAGE DIFFERENTIATION COMPRISING CARTILAGE CELL-FREE CRUSH AND STEM CELL AND USE THEREOF

#1106 ✅ Patent 11,413,316 granted on 2022-08-16
US20190365821A1
Human necessities

In vitro production of muscle stem cells

#1107
US20190365822A1
Human necessities

CARDIAC PROGENITOR CELLS HAVING ENHANCED p53 EXPRESSION AND USES THEREOF

#1108
US20190365823A1
Human necessities

ENCAPSULATED INTESTINAL MIDGUT ENDODERM CELLS

#1109 ✅ Patent 11,020,437 granted on 2021-06-01
US20190365824A1
Human necessities

Methods for treating nuclear factor kappa-light-chain-enhancer of activated B cell (NF-KB) dysregulation in a host in need thereof using eggshell membrane compositions

#1110 ✅ Patent 11,077,152 granted on 2021-08-03
US20190365825A1
Human necessities

Method of producing nasal drop composition by mixing earthworm castings with water

#1111 ✅ Patent 10,576,108 granted on 2020-03-03
US20190365826A1
Human necessities

Tau protein production accelerator, and therapeutic or preventive agent and therapeutic or preventive food composition for diseases caused by tau protein deficiency

#1112
US20190365827A1
Human necessities

COMPOSITION FOR TREATING DIABETIC DISEASE

#1113 ✅ Patent 10,933,101 granted on 2021-03-02
US20190365828A1
Human necessities

Fermented product and production method therefor

#1114 ✅ Patent 11,571,446 granted on 2023-02-07
US20190365829A1
Human necessities

Gut microbiota and treatment of cancer

#1115
US20190365830A1
Human necessities

METHODS OF TREATING CANCER

#1116
US20190365831A1
Human necessities

MICROBIOTA RESTORATION THERAPY (MRT), COMPOSITIONS AND METHODS OF MANUFACTURE

#1117 ✅ Patent 11,633,437 granted on 2023-04-25
US20190365832A1
Human necessities

Compositions and methods for treating inflammatory related diseases or conditions using probiotics

#1118 ✅ Patent 11,338,001 granted on 2022-05-24
US20190365833A1
Human necessities

Probiotics for aggregation with disease-associated species in the oral cavity

#1119
US20190365834A1
Human necessities

Bacteriophage Compositions And Methods Of Selection Of Components Against Specific Bacteria

#1120 ✅ Patent 11,000,561 granted on 2021-05-11
US20190365835A1
Human necessities

Adeno-associated virus purification methods

#1121 ✅ Patent 11,865,150 granted on 2024-01-09
US20190365836A1
Human necessities

Materials and methods for treating cancer

#1122
US20190365837A1
Human necessities

ANTI-NASH COMPOSITION, FOOD COMPOSITION FOR PREVENTING NASH, BEVERAGE COMPOSITION FOR PREVENTING NASH, COMPOSITION FOR PREVENTING CIRRHOSIS, AND COMPOSITION FOR PREVENTING HEPATOCELLULAR CARCINOMA

#1123 ✅ Patent 11,273,192 granted on 2022-03-15
US20190365838A1
Human necessities

Method of producing ginseng leaf extract including ginsenosides Rg6, Rk3, and Rh4 in increased amounts from ginseng leaf and use of the ginseng leaf extract

#1124 ✅ Patent 11,071,764 granted on 2021-07-27
US20190365839A1
Human necessities

Synergistic dietary supplement compositions of and for liver health

#1125 ✅ Patent 11,040,079 granted on 2021-06-22
US20190365840A1
Human necessities

Compositions derived from and methods of use for cancer treatment

#1126 ✅ Patent 10,561,695 granted on 2020-02-18
US20190365841A1
Human necessities

Composition having functions of improving kidney yang, enhancing immunity and relieving fatigue, method for producing the same and use thereof

#1127 ✅ Patent 11,135,259 granted on 2021-10-05
US20190365842A1
Human necessities

Compositions and methods for increasing nitric oxide levels for male performance

#1128
US20190365843A1
Human necessities

Antimicrobial Activity of Bioactive Compounds and Their Derivatives

#1129 ✅ Patent 11,000,565 granted on 2021-05-11
US20190365844A1
Human necessities

Methods of increasing muscle mass by administration of activin type 2 receptor antibodies

#1130
US20190365845A1
Human necessities

METHODS FOR PERFORMING A CORONARY ARTERY BYPASS GRAFT PROCEDURE

#1131
US20190365846A1
Human necessities

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY

#1132
US20190365847A1
Human necessities

IMPLANTABLE DEVICE FOR THE DELIVERY OF OCTREOTIDE AND METHODS OF USE THEREOF

#1133 ✅ Patent 11,364,277 granted on 2022-06-21
US20190365848A1
Human necessities

Treatment of ascites

#1134 ✅ Patent 11,602,467 granted on 2023-03-14
US20190365849A1
Human necessities

Absorbent structure for absorbent articles

#1135 ✅ Patent 11,116,817 granted on 2021-09-14
US20190365850A1
Human necessities

Antimicrobial agents and compositions comprising the same

#1136 ✅ Patent 11,026,994 granted on 2021-06-08
US20190365851A1
Human necessities

Syndecan-2 compositions and methods of use

#1137
US20190365852A1
Human necessities

RECOMBINANT BACULOVIRUSES AND USES THEREOF

#1138
US20190365853A1
Human necessities

COMPOSITIONS AND RELATED METHODS FOR CONTROLLING VECTOR-BORNE DISEASES

#1139
US20190365854A1
Human necessities

APOAEQUORIN AND VITAMIN D-CONTAINING COMPOSITIONS AND METHODS OF USING SAME

#1140 ✅ Patent 10,751,388 granted on 2020-08-25
US20190365855A1
Human necessities

Use of recombinant lymphocyte activation gene-3 as a companion therapeutic for patients at risk for cardiovascular disease and other chronic inflammatory diseases

#1141
US20190365856A1
Human necessities

Method of selecting agents for the treatment of pain using neuronal differentiation

#1142 ✅ Patent 11,027,014 granted on 2021-06-08
US20190365857A1
Human necessities

Methods using GDF-15 antibodies for treatment of pulmonary arterial hypertension

#1143
US20190365858A1
Human necessities

METHODS AND COMPOSITIONS FOR REJUVENATING NEUROMUSCULAR JUNCTIONS

#1144 ✅ Patent 11,819,537 granted on 2023-11-21
US20190365859A1
Human necessities

Preventive or therapeutic method for inflammatory skin disease

#1145 ✅ Patent 11,160,848 granted on 2021-11-02
US20190365860A1
Human necessities

Methods of treating gastrointestinal sphincter deficiency disorders

#1146
US20190365861A1
Human necessities

IL-15/IL-15RA HETERODIMERIC FC FUSION PROTEINS AND USES THEREOF

#1147
US20190365862A1
Human necessities

COMBINATION THERAPIES FOR ERADICATING FLAVIVIRUS INFECTIONS IN SUBJECTS

#1148
US20190365863A1
Human necessities

METHODS AND MATERIALS FOR TREATING FUNCTIONAL DYSPEPSIA

#1149
US20190365864A1
Human necessities

TREATMENT OF PEDIATRIC TYPE 2 DIABETES MELLITUS PATIENTS

#1150 ✅ Patent 10,905,745 granted on 2021-02-02
US20190365865A1
Human necessities

Acylated GLP-1/GLP-2 dual agonists

#1151 ✅ Patent 11,110,151 granted on 2021-09-07
US20190365866A1
Human necessities

Composition and method for reducing hypoglycemia events in diabetes treatment

#1152 ✅ Patent 11,471,513 granted on 2022-10-18
US20190365867A1
Human necessities

Highly glycosylated human blood-clotting factor VIII fusion protein, and manufacturing method and application of same

#1153 ✅ Patent 11,541,105 granted on 2023-01-03
US20190365868A1
Human necessities

Compositions and methods for disrupting biofilm formation and maintenance

#1154
US20190365869A1
Human necessities

Bioresponsive Particles

#1155
US20190365870A1
Human necessities

DYSTROPHIN GENE EXON DELETION USING ENGINEERED NUCLEASES

#1156
US20190365871A1
Human necessities

DRUG FOR PREVENTING AND TREATING OSTEOPOROSIS AND USES THEREOF

#1157 ✅ Patent 11,071,772 granted on 2021-07-27
US20190365872A1
Human necessities

Method for preventing and treating tissue and organ fibrosis

#1158 ✅ Patent 10,828,348 granted on 2020-11-10
US20190365873A1
Human necessities

Treatment of social anxiety disorder, obsessive compulsive disorder and panic disorder using botulinum toxin

#1159
US20190365874A1
Human necessities

COMPOSITIONS AND METHODS FOR TREATING OR AMELIORATING FIBROSIS, SYSTEMIC SCLEROSIS, SCLERODERMA AND GRAFT VERSUS HOST DISEASE

#1160 ✅ Patent 11,311,609 granted on 2022-04-26
US20190365875A1
Human necessities

Regulating chimeric antigen receptors

#1161
US20190365876A1
Human necessities

HLA Class II Deficient Cells, HLA Class I Deficient Cells Capable of Expressing HLA Class II Proteins, and Uses Thereof

#1162
US20190365877A1
Human necessities

Compositions Comprising Apoptotic Signaling and Methods for Induction of Antigen-Specific Tolerance

#1163
US20190365878A1
Human necessities

PHARMACEUTICAL TREATMENTS FOR PREVENTING OR TREATING PANCREATIC CANCER

#1164 ✅ Patent 12,048,738 granted on 2024-07-30
US20190365879A1
Human necessities

Composition for treating prostate cancer (PCa)

#1165 ✅ Patent 10,960,066 granted on 2021-03-30
US20190365880A1
Human necessities

vaccine

#1166 ✅ Patent 11,090,376 granted on 2021-08-17
US20190365881A1
Human necessities

Effective vaccination against European strains of porcine reproductive and respiratory syndrome (PRRS) virus prior to weaning

#1167 ✅ Patent 10,953,086 granted on 2021-03-23
US20190365882A1
Human necessities

Universal influenza vaccine using cold-adapted live-attenuated virus

#1168
US20190365883A1
Human necessities

Influenza Peptides and Compositions

#1169 ✅ Patent 10,874,734 granted on 2020-12-29
US20190365884A1
Human necessities

Varicella zoster virus vaccine

#1170 ✅ Patent 11,007,264 granted on 2021-05-18
US20190365885A1
Human necessities

Mixed allergen compositions and methods for using the same

#1171
US20190365886A1
Human necessities

VACCINE COMPOSITIONS

#1172 ✅ Patent 10,874,737 granted on 2020-12-29
US20190365887A1
Human necessities

Influenza nanovaccine

#1173
US20190365888A1
Human necessities

COMPOSITIONS AND METHODS OF TREATING LUPUS NEPHRITIS

#1174 ✅ Patent 10,869,925 granted on 2020-12-22
US20190365889A1
Human necessities

Catheter package including catheter straightening means

#1175
US20190365890A1
Human necessities

A B Cell Depleting Agent for the Treatment of Atherosclerosis

#1176 ✅ Patent 11,135,291 granted on 2021-10-05
US20190365891A1
Human necessities

Methods for making and using anti-myostatin antibodies

#1177 ✅ Patent 11,083,791 granted on 2021-08-10
US20190365892A1
Human necessities

Anti-VLA-4 antibodies

#1178 ✅ Patent 11,446,378 granted on 2022-09-20
US20190365893A1
Human necessities

Inhibitors of ephrin B1 for tumor treatment

#1179 ✅ Patent 10,869,927 granted on 2020-12-22
US20190365894A1
Human necessities

Human endothelin receptor antibody and use thereof

#1180 ✅ Patent 10,835,603 granted on 2020-11-17
US20190365895A1
Human necessities

Method for normalizing blood vessels of lesions by oxygen-loaded microbubbles and ultrasonic irradiation

#1181 ✅ Patent 11,246,929 granted on 2022-02-15
US20190365896A1
Human necessities

Combination of a protein kinase inhibitor and an additional chemotherapeutic agent

#1182
US20190365897A1
Human necessities

THERAPEUTIC COMPOSITIONS AND RELATED METHODS FOR PHOTOIMMUNOTHERAPY

#1183 ✅ Patent 11,191,836 granted on 2021-12-07
US20190365898A1
Human necessities

Biodegradable nanocarrier(s) (BPMOs) for neutron capture therapy and methods thereof

#1184
US20190365899A1
Human necessities

Retinoid Topical Compositions and Methods for Treating Skin Conditions

#1185 ✅ Patent 11,083,796 granted on 2021-08-10
US20190365900A1
Human necessities

Peroxide removal from drug delivery vehicle

#1186
US20190365901A1
Human necessities

Method for the Treatment of a Solid Tumour

#1187 ✅ Patent 11,419,941 granted on 2022-08-23
US20190365902A1
Human necessities

Vaginal hydrogel

#1188 ✅ Patent 11,351,262 granted on 2022-06-07
US20190365903A1
Human necessities

Method for stabilization and delivery of therapeutic molecules

#1189 ✅ Patent 10,821,188 granted on 2020-11-03
US20190365904A1
Human necessities

Luteinizing hormone-releasing hormone receptor (LHRH-R) conjugates and uses thereof

#1190 ✅ Patent 10,987,428 granted on 2021-04-27
US20190365905A1
Human necessities

Phosphorothioate-conjugated miRNAs and methods of using the same

#1191
US20190365906A1
Human necessities

RANDOM COPOLYMER THERAPEUTIC AGENT CARRIERS AND ASSEMBLIES THEREOF

#1192
US20190365907A1
Human necessities

ZWITTERIONIC POLYMER-INSULIN COMPOSITIONS AND RELATED METHODS

#1193 ✅ Patent 10,881,739 granted on 2021-01-05
US20190365908A1
Human necessities

Interleukin-11 PEGylation reaction intermediate composition

#1194 ✅ Patent 10,946,103 granted on 2021-03-16
US20190365909A1
Human necessities

Methods of treatment using a branched amino terminal pegylated Il-11 composition

#1195 ✅ Patent 10,660,969 granted on 2020-05-26
US20190365910A1
Human necessities

Eight-arm polyethylene glycol derivative, production method therefor, and modified bio-related substance thereof

#1196 ✅ Patent 10,918,731 granted on 2021-02-16
US20190365911A1
Human necessities

HSP90 inhibitory peptide conjugate and application thereof in treating tumor

#1197 ✅ Patent 10,596,269 granted on 2020-03-24
US20190365912A1
Human necessities

Delivering enhanced active agents

#1198
US20190365913A1
Human necessities

STAPLED PEPTIDE CONJUGATES AND PARTICLES

#1199 ✅ Patent 11,278,627 granted on 2022-03-22
US20190365914A1
Human necessities

Antibody-drug conjugates and the use of same in therapy

#1200 ✅ Patent 10,898,578 granted on 2021-01-26
US20190365915A1
Human necessities

Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making